New selective licensing powers
- Reference: 2025/0777
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
Planning and Housing Practice Note December 2024
- Reference: 2025/0776
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
New SHMA and SHLAA
- Reference: 2025/0775
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
MPS drugs strategy (2)
- Reference: 2025/0774
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
Child Q officers’ misconduct
- Reference: 2025/0773
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
MPS officers carrying naloxone (2)
- Reference: 2025/0772
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
Drug deaths and coroners (2)
- Reference: 2025/0771
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
Business case for current drugs approach
- Reference: 2025/0770
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
Business case for live facial recognition
- Reference: 2025/0769
- Question by: Zoë Garbett
- Meeting date: 25 February 2025
London Drugs Commission publication
- Reference: 2025/0768
- Question by: Zoë Garbett
- Meeting date: 25 February 2025